Aries Wealth Management Forte Biosciences, Inc. Transaction History

Aries Wealth Management

  • $359 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022
BUY
$1.07 - $1.55 $13,910 - $20,150
13,000 New
13,000 $17,000
Q1 2022

Apr 25, 2022
SELL
$1.21 - $2.24 $15,730 - $29,120
-13,000 Closed
0 $0
Q4 2021

Jun 06, 2022
SELL
$2.02 - $3.36 $157,560 - $262,080
-78,000 Reduced 85.71%
13,000 $28,000
Q4 2021

Jan 18, 2022
BUY
$2.02 - $3.36 $183,820 - $305,760
91,000 New
91,000 $195,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $371M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Aries Wealth Management Portfolio

Follow Aries Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aries Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aries Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email